Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
78 studies found for:    Open Studies | "Rectal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Condition: Rectal Neoplasms
Interventions: Drug: Oxaliplatin;   Drug: capecitabine;   Radiation: Radiation
22 Unknown  Anterior Perineal Plane for Ultra Low Anterior Resection of the Rectum
Conditions: Rectal Neoplasms;   Colitis, Ischemic;   Colitis, Ulcerative
Interventions: Procedure: Standard abdominal approach for rectal excision;   Procedure: APPEAR Procedure;   Procedure: Proctectomy
23 Recruiting Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Conditions: Rectal Diseases;   Rectal Neoplasms;   Gastrointestinal Diseases;   Gastrointestinal Neoplasms
Intervention: Procedure: new functional magnetic resonance imaging (MRI) protocols
24 Recruiting Functional Outcome of Organ Preservation After Neo-adjuvant Chemo Radiation for Rectal Cancer
Condition: Rectal Neoplasms
Interventions: Other: Questionnaires for the evaluation of Quality of Life;   Other: Manometry
25 Recruiting Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery
Condition: Rectal Neoplasms
Interventions: Radiation: fludeoxyglucose F 18;   Device: positron emission tomography;   Device: magnetic resonance imaging;   Other: laboratory biomarker analysis
26 Unknown  Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
Conditions: Adenocarcinoma;   Rectal Neoplasms
Interventions: Other: 18F- FDG PET scans;   Other: DW-MRI scans
27 Recruiting Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer
Condition: Rectal Neoplasms
Intervention:
28 Recruiting [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Conditions: Uterine Cervical Neoplasms;   Endometrial Neoplasms;   Anus Neoplasms;   Rectal Neoplasms;   Prostatic Neoplasms
Intervention: Radiation: Bone marrow sparing IMRT radiation therapy
29 Recruiting Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
Condition: Rectal Neoplasms
Intervention: Radiation: preoperative short-course radiotherapy
30 Recruiting Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer
Condition: Rectal Neoplasms
Intervention: Procedure: endoscopic posterior mesorectal resection
31 Unknown  Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
Conditions: Colorectal Neoplasm;   Iron Deficiency Anemia
Interventions: Drug: i.v. iron sucrose;   Drug: Oral iron
32 Recruiting Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer
Conditions: Rectal Tumors;   Erectile Dysfunction
Intervention: Other: vacuum erection device
33 Unknown  Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal Cancer
Condition: Rectal Tumour
Interventions: Drug: Capecitabine;   Radiation: radiotherapy;   Procedure: TME resection;   Procedure: TEM surgery
34 Recruiting Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients
Condition: Rectum Neoplasms
Interventions: Procedure: L-PANP-TME;   Procedure: O-PANP-TME
35 Recruiting Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients
Condition: Rectum Neoplasms
Interventions: Procedure: L-PANP-TME;   Procedure: O-PANP-TME
36 Recruiting Evaluation of Rectal Tumor Margin Using Confocal Endomicroscopy and Comparison to Histopathology
Conditions: Rectal Cancer;   Rectal Adenocarcinoma
Interventions: Device: Probe-based confocal laser endomicroscopy;   Procedure: Rectoscopy;   Procedure: EUS;   Procedure: Biopsy and resection
37 Recruiting Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adenocarcinoma of Unknown Primary;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Diffuse Adenocarcinoma of the Stomach;   Duct Cell Adenocarcinoma of the Pancreas;   Intestinal Adenocarcinoma of the Stomach;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Carcinoma of Unknown Primary;   Metastatic Extrahepatic Bile Duct Cancer;   Mixed Adenocarcinoma of the Stomach;   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Newly Diagnosed Carcinoma of Unknown Primary;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage III Pancreatic Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIA Gastric Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Gallbladder Cancer;   Stage IIIB Gastric Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Gastric Cancer;   Stage IIIC Rectal Cancer;   Stage IV Gastric Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Colon Cancer;   Stage IVA Gallbladder Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Gallbladder Cancer;   Stage IVB Rectal Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: oxaliplatin;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Other: laboratory biomarker analysis
38 Recruiting Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Conditions: Recurrent Rectal Cancer;   Stage IIA Rectal Cancer;   Stage IIB Rectal Cancer;   Stage IIC Rectal Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Rectal Cancer
Interventions: Drug: trametinib;   Drug: fluorouracil;   Radiation: radiation therapy
39 Recruiting Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
Conditions: Adenocarcinoma of the Lung;   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Squamous Cell Lung Cancer;   Stage I Colon Cancer;   Stage I Rectal Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Colon Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIA Rectal Cancer;   Stage IIB Colon Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIB Rectal Cancer;   Stage IIC Colon Cancer;   Stage IIC Rectal Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer
Interventions: Other: educational intervention;   Other: medical chart review
40 Recruiting Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Conditions: Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage IV Colon Cancer;   Stage IV Rectal Cancer
Interventions: Biological: aflibercept;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: fluorouracil;   Other: Correlative Studies;   Procedure: DCE MRI;   Radiation: f18FDG-PET;   Procedure: PET (positron emission tomography)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years